NEW ORLEANS — Using hypotonic riboflavin to induce swelling in the cornea can protect patients with keratoconus from endothelial toxicity during crosslinking, according to Julia Yu, at Academy ’23.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback